Voxel Rad, Ltd.

12 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Sep 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Feb 27, 2027
The maintenance fee for Systems and methods for 3D stereoscopic angiovision, angionavigation and angiotherapeutics (US 10,391,277) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
2 fees due Sep 29, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,295,491	Systems and Methods for Treating Cancer Using Brachytherapy In force Term ends Sep 16, 2030 · High confidence	In force	Term ends Sep 16, 2030	High confidence
US 9,295,856	Systems and Methods for Treating Cancer Using Brachytherapy In force Term ends Sep 16, 2030 · High confidence	In force	Term ends Sep 16, 2030	High confidence
US 11,491,346	Systems and Methods for Treating Cancer Using Brachytherapy In force Term ends Sep 16, 2030 · Low confidence	In force	Term ends Sep 16, 2030	Low confidence
US 10,016,619	Systems and Methods for Treating Cancer Using Brachytherapy In force Term ends Jan 18, 2031 · High confidence	In force	Term ends Jan 18, 2031	High confidence
US 9,649,168	Systems and methods for frameless image-guided biopsy and therapeutic intervention In force Term ends Apr 16, 2031 · From the USPTO record	In force	Term ends Apr 16, 2031	From the USPTO record
US 8,758,263	Systems and methods for frameless image-guided biopsy and therapeutic intervention In force Term ends May 31, 2032 · From the USPTO record	In force	Term ends May 31, 2032	From the USPTO record
US 11,577,049	Systems and methods for 3D stereoscopic angiovision, angionavigation and angiotherapeutics In force Term ends Jul 1, 2034 · From the USPTO record	In force	Term ends Jul 1, 2034	From the USPTO record
US 10,391,277	Systems and methods for 3D stereoscopic angiovision, angionavigation and angiotherapeutics In force Term ends Jan 6, 2035 · From the USPTO record	In force	Term ends Jan 6, 2035	From the USPTO record
US 12,137,882	Systems and Methods for Treating Cancer Using Brachytherapy In force Term ends Oct 20, 2035 · High confidence	In force	Term ends Oct 20, 2035	High confidence
US 12,685,879	Treating Cancer Using Intensity-Modulated Brachytherapy In force Term ends Oct 20, 2035 · High confidence	In force	Term ends Oct 20, 2035	High confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

List them